20
Participants
Start Date
November 12, 2015
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
Mocetinostat
Mocetinostat is taken orally at 70 mg/dose, 3 days per week, during cycle 1. Dose is increased to 90 mg starting at cycle 2.
Gemcitabine
Gemcitabine is administered via intravenous infusion at 1,000 mg/m2 at a rate of approximately 10 mg/m2/minute, on days 5 and 12 of every cycle.
Memorial Sloan Kettering Cancer Center, New York
Ohio State University, Columbus
University of Michigan, Ann Arbor
University of Texas MD Anderson Cancer Center, Houston
Massachusetts General Hospital/Dana Farber Cancer Institute, Boston
Sarcoma Alliance for Research through Collaboration
OTHER